Regencell Bioscience Holdings Limited
RGC
Kedudukan dalam Saham
#3376
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Harga Saham
$10.41
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$5.16B
Perubahan (1 hari)
3.56%
Perubahan (1 tahun)
-35.07%
Negara
HK
Perdagangan Regencell Bioscience Holdings Limited (RGC)
Kategori
Healthcare
Bilangan saham terbitan bagi Regencell Bioscience Holdings Limited (RGC)
Bilangan saham terbitan setakat June 2026: 494.70M
Menurut laporan kewangan terkini dan harga saham Regencell Bioscience Holdings Limited, bilangan saham terbitan semasa ialah 494.70M. Pada akhir June 2024, syarikat mempunyai 494.49M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Regencell Bioscience Holdings Limited (RGC) dari 2019 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2026 (TTM) | 494.70M | 0.04% |
| 2025 | 494.49M | 0.00% |
| 2024 | 494.49M | 0.00% |
| 2023 | 494.49M | 0.00% |
| 2022 | 494.49M | 2.93% |
| 2021 | 480.40M | 0.00% |
| 2020 | 480.40M | 0.00% |
| 2019 | 480.40M | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 385.01% |
IN
|
